Cereal β-glucan fibre drink as a part of nutritionally balanced diet alters lipid profile: An intervention study

Asian Journal of Plant Sciences

Volumn 11, Issue 3, 2012, Pages 153-156

  Mikušová, Lucia ^a   Penesová, Adela ^b   Valachovièčová, Martina ^c   Holubková, Andrea ^a   Mikuš, Lubomir ^a   Šturdik, Ernest ^a  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^c SLOVAK MEDICAL UNIVERSITY   (Slovakia)

Author keywords

Atherogenic index; Cholesterol; Weight management; glucan fibre drink

Indexed keywords

HORDEUM;

EID: 84862904043     PISSN: 16823974     EISSN: 18125697     Source Type: Journal    
DOI: 10.3923/ajps.2012.153.156     Document Type: Article

References (16)

1. Aman, P., 2006. Cholesterol-lowering effects of barley dietary fibre in humans: scientific support for a generic health claim. Scand. J. Food Nutr., 50: 173-176.
2. Ames, N. and C. Rhymer, 2008. Issues surrounding health claims for barley. J. Nutr., 138: 1237S-1243S.
3. Brennan, C.S. and L.J. Cleary, 2005. The potential use of cereal (1 →3,1 → 4)-β-glucans as functional food ingredients. J. Cereal Sci., 42: 1-13.
4. Brown, L., B. Rosner, W.W. Willett and F.M. Sacks, 1999. Cholesterol-lowering effects of dietary fiber: A meta-analysis. Am. J. Clin. Nutr., 69: 30-42.
5. FDA, 1997. Final rule for food labelling: Health claims: Oats and coronary heart disease. Fed. Regulations, 62: 3584-3681.
6. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 18: 499-502.
7. Havrlentova, M., Z. Petrulakova, A. Burgarova, F. Gago, A. Hlinkova and E. Sturdik, 2011. Cereal β-glucans and their significance for the preparation of functional foods- a review. Czech J. Food Sci., 29: 1-14.
8. Keenan, J.M., M. Goulson, T. Shamliyan, N. Knutson, L. Kolberg and L. Cuny, 2007. The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women. Br. J. Nutr., 97: 1162-1168.
9. Krajcovicova-Kudlackova, M., P. Blazicek, V. Spustova, M. Valachovicovaand, E. Ginter, 2004. Cardiovascular risk factors in young Gypsy population. Bratisl Lek Listy, 105: 256-259.
10. Lovegrove, J.A., A. Clohessy, H. Milon and C.M. Williams, 2000. Modest doses of β-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am. J. Clin. Nutr., 72: 49-55.
11. Mikusova, L., E. Sturdik and A. Holubkova, 2011. Whole grain cereal food in prevention of obesity. Acta Chimica Slovaca, 4: 95-114.
12. Poppit, S.D., 2007. Soluble fibre oat and barley β-glucan enriched products: Can we predict cholesterol-lowering effects?. Br. J. Nutr., 97: 1049-1050.
13. Ripsin, C.M., J.M. Keenan, D.R. Jacobs, P.J. Elmer and R.R. Welch et al., 1992. Oat products and lipid lowering. A meta-analysis. J. Am. Med. Assoc., 267: 3317-3325.
14. Smith, K.N., K.M. Queenan, W. Thomas, RG. Fulcher and J.L. Slavin, 2008. Physiological effects of concentrated barley β-glucan in mildly hypercholesterolemic adults. J. Am. Coll. Nutr., 27: 434-440.
15. Tiwari, U. and E. Cummins, 2011. Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels. Nutr., 27: 1008-1016.
16. Wood, P.J., 2007. Cereal β-glucans in diet and health. J. Cereal Sci., 46: 230-238.